The FDA has granted rare pediatric disease designation to Stealth BioTherapeutics' candidate elamipretide as a treatment for Barth syndrome, a rare inherited condition.
Elamipretide gains rare pediatric disease tag
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.